Skip to content

Clinical trials

Esophageal Squamous Cell Carcinoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Country / region: Japan Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20071
20161
20171
20182
20192
20206
20212
20222
20233
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed9
Terminated6
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
AstraZeneca3
Novartis Pharmaceuticals3
BeiGene2
National Cancer Center, Japan2
AbbVie1
Astellas Pharma Global Development, Inc.1
Bayer1
BeOne Medicines1
City of Hope Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma29
Squamous Cell Carcinoma of Head and Neck9
Carcinoma, Non-Small-Cell Lung4
Esophageal Neoplasms4
Carcinoma, Hepatocellular3
Neoplasm Metastasis3
Small Cell Lung Carcinoma3
Triple Negative Breast Neoplasms3
Stomach Neoplasms2
Uterine Cervical Neoplasms2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.